Related Experiment Videos
[Typification of HPV in clinical practice]
U Wiesenfeld1, M Comar, P D'Agaro
1Clinica Ginecologica ed Ostetrica dell'Università di Trieste, IRCCS "Burlo Garofalo", Via dell'Istria, 65/1, 34137 Trieste.
Minerva Ginecologica
|August 31, 2001
Summary
Combining liquid-based cytology (ThinPrep) and HPV DNA testing significantly improves cervical cancer screening sensitivity. For ASCUS Pap results, HPV testing efficiently identifies high-risk cases, potentially reducing unnecessary colposcopies.
Area of Science:
- Gynecologic Oncology
- Cytopathology
- Molecular Diagnostics
Context:
- Cervical cancer screening aims to detect precancerous lesions early.
- Atypical Squamous Cells of Undetermined Significance (ASCUS) Pap results require careful management to balance sensitivity and specificity.
- Conventional Pap smears have limitations in sensitivity for detecting cervical dysplasia.
Purpose:
- To evaluate the effectiveness of combining ThinPrep liquid-based cytology with HPV DNA testing for improving cervical carcinoma screening sensitivity.
- To determine the optimal management strategy for patients with ASCUS Pap results using integrated diagnostic approaches.
Summary:
- A study involving 170 women compared conventional Pap smears with ThinPrep liquid-based cytology and HPV DNA testing, followed by colposcopy and histology.
- ThinPrep demonstrated higher sensitivity for detecting high-grade lesions compared to conventional smears.
- HPV DNA testing on residual specimens from ASCUS cases identified 100% of high-grade and 67% of low-grade lesions. Limiting colposcopy to HPV-positive women could spare 47% of procedures.
Impact:
- Liquid-based cytology enhances the detection of cervical disease.
- HPV DNA testing integrated with ASCUS cytology effectively identifies women with high-risk HPV infections, guiding clinical management.
- This combined approach offers a more sensitive and potentially cost-effective strategy for cervical cancer screening and triage.